New Treatment for GEP-NETs Approved in Canada
<a href="https://pixabay.com/users/Parentingupstream/">Parentingupstream</a> / Pixabay

New Treatment for GEP-NETs Approved in Canada

According to a story from pm360online.com, the Novartis company Advanced Accelerator Applications S.A. recently announced that Health Canada has issued approval for Lutathera™ as a treatment for gasteroenteropancreatic neuroendocrine tumors…

Continue Reading
Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
<a href="https://pixabay.com/users/sabinurce/">sabinurce</a> / Pixabay

Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia

According to a story from Market Screener, the biopharmaceutical company Orchard Therapeutics recently announced that the results of a recent clinical trial testing the company' investigational product OTL-300 were encouraging.…

Continue Reading
Possible Treatment for Niemann-Pick Disease Type C Performs Well in Clinical Trial
<a href="https://pixabay.com/users/DarkoStojanovic/">DarkoStojanovic</a> / Pixabay

Possible Treatment for Niemann-Pick Disease Type C Performs Well in Clinical Trial

According to a story from labiotech.eu, the biotechnology company Orphazyme has been developing an experimental therapy for Niemann-Pick disease type C. In a recent Phase 2/3 clinical trial, the investigational…

Continue Reading
Close Menu